Radiation and Cancer Biology

EDU 25 (Live SA-CME) - Translational Genomics to Advance Precision Radiation Oncology

Using genomics to inform rationale combination therapies

Tuesday, October 23
2:00 PM - 2:20 PM
Location: Room 006

Kent Mouw, MD, PhD

Disclosure:
Employment
Brigham & Women's Hospital/Dana-Farber Cancer Inst: Instructor: Employee

Biography:
Kent W Mouw, MD, PhD is a radiation oncology physician-scientist at Dana-Farber Cancer Institute/Brigham & Women's Hospital and an Instructor in Medicine at Harvard Medical School. He obtained his medical and graduate degrees from the University of Chicago and completed a radiation oncology residency in the Harvard Radiation Oncology Program and a post-doctoral research fellowship at Dana-Farber Cancer Institute. In addition to providing radiation oncology care for patients with genitourinary malignancies, Dr. Mouw oversees a basic and translational research laboratory that investigates the role of DNA repair pathway alterations in bladder cancer and other tumor types.

Presentation(s):

Send Email for Kent Mouw


Assets

Using genomics to inform rationale combination therapies



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Using genomics to inform rationale combination therapies